BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11716667)

  • 1. Aspirin and epithelial ovarian cancer.
    Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
    Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular use of analgesic drugs and ovarian cancer risk.
    Moysich KB; Mettlin C; Piver MS; Natarajan N; Menezes RJ; Swede H
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):903-6. PubMed ID: 11489759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic drug use and risk of epithelial ovarian cancer.
    Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
    Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular analgesic use and risk of endometrial cancer.
    Moysich KB; Baker JA; Rodabaugh KJ; Villella JA
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2923-8. PubMed ID: 16365011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
    Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
    Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of analgesic use and ovarian cancer.
    Rosenberg L; Palmer JR; Rao RS; Coogan PF; Strom BL; Zauber AG; Stolley PD; Shapiro S
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):933-7. PubMed ID: 11008911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular analgesic use and risk of multiple myeloma.
    Moysich KB; Bonner MR; Beehler GP; Marshall JR; Menezes RJ; Baker JA; Weiss JR; Chanan-Khan A
    Leuk Res; 2007 Apr; 31(4):547-51. PubMed ID: 16962170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW; Anderson KE; Lazovich D; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
    Zhang M; Xie X; Holman CD
    Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States).
    Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Gebretsadik T; Hampton JM; Stampfer MJ; Willett WC; Egan KM
    Cancer Causes Control; 2006 May; 17(4):459-67. PubMed ID: 16596298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study.
    Anderson JP; Ross JA; Folsom AR
    Cancer; 2004 Apr; 100(7):1515-21. PubMed ID: 15042687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.